Citation Impact
Citing Papers
The Effect of a Hypocaloric Diet with and without Exercise Training on Body Composition, Cardiometabolic Risk Profile, and Reproductive Function in Overweight and Obese Women with Polycystic Ovary Syndrome
2008
The Istanbul consensus workshop on embryo assessment: proceedings of an expert meeting
2011 Standout
Metabolic and Endocrine Effects of a Polyunsaturated Fatty Acid-Rich Diet in Polycystic Ovary Syndrome
2004
Sheep models of polycystic ovary syndrome phenotype
2012
The Pancreas Is Altered by In Utero Androgen Exposure: Implications for Clinical Conditions Such as Polycystic Ovary Syndrome (PCOS)
2013
Depression, anxiety and cardiometabolic risk in polycystic ovary syndrome
2011
Overweight Women with Polycystic Ovary Syndrome Have Evidence of Subclinical Cardiovascular Disease
2005
Glucose Intolerance in Obese Adolescents with Polycystic Ovary Syndrome: Roles of Insulin Resistance and β-Cell Dysfunction and Risk of Cardiovascular Disease1
2001
The Prevalence and Features of the Polycystic Ovary Syndrome in an Unselected Population
2004 Standout
Thiazolidinediones
2004 Standout
Impaired cholecystokinin secretion and disturbed appetite regulation in women with polycystic ovary syndrome
2004
Cardiovascular Disease and Risk Factors in PCOS Women of Postmenopausal Age: A 21-Year Controlled Follow-Up Study
2011
Mortality of Women with Polycystic Ovary Syndrome at Long-term Follow-up
1998
The effect of fat removal on glucose tolerance is depot specific in male and female mice
2007
Emotional distress is a common risk in women with polycystic ovary syndrome: a systematic review and meta-analysis of 28 studies
2012
Pregnancy complications in PCOS
2006
Variation within the Type 2 Diabetes Susceptibility Gene Calpain-10 and Polycystic Ovary Syndrome
2002
Effect of an oral contraceptive on emotional distress, anxiety and depression of women with polycystic ovary syndrome: a prospective study
2012
Prevalence and implications of anxiety in polycystic ovary syndrome: results of an internet-based survey in Germany
2009
High ovulatory rates with use of troglitazone in clomiphene-resistant women with polycystic ovary syndrome
1999
BMI-Associated Alleles Do Not Constitute Risk Alleles for Polycystic Ovary Syndrome Independently of BMI: A Case-Control Study
2014
Polycystic ovarian syndrome (PCOS): Long-term metabolic consequences
2017
Type 2 diabetes mellitus after gestational diabetes: a systematic review and meta-analysis
2009 Standout
Polymorphism of the interleukin‐10 gene in polycystic ovary syndrome
2008
The polycystic ovary syndrome: a position statement from the European Society of Endocrinology
2014
Gestational diabetes mellitus
2005 Standout
Insulin resistance, polycystic ovary syndrome, and type 2 diabetes mellitus
2002
A 27-Year-Old Woman With a Diagnosis of Polycystic Ovary Syndrome
2007
Retinol-binding protein 4 levels are elevated in polycystic ovary syndrome women with obesity and impaired glucose metabolism
2007
Evidence for pancreatic β-cell dysfunction in brothers of women with polycystic ovary syndrome
2007
Androgen conversion in osteoarthritis and rheumatoid arthritis synoviocytes – androstenedione and testosterone inhibit estrogen formation and favor production of more potent 5α-reduced androgens
2005
Cellular Insulin Resistance in Adipocytes from Obese Polycystic Ovary Syndrome Subjects Involves Adenosine Modulation of Insulin Sensitivity1
1997
Obesity and the risk of myocardial infarction in 27 000 participants from 52 countries: a case-control study
2005 Standout
Selective effects of pioglitazone on insulin and androgen abnormalities in normo- and hyperinsulinaemic obese patients with polycystic ovary syndrome
2003
The central issue? Visceral fat mass is a good marker of insulin resistance and metabolic disturbance in women with polycystic ovary syndrome
2006
Prevalence of adrenal androgen excess in patients with the polycystic ovary syndrome (PCOS)
2005
Pituitary desensitization to gonadotropin-releasing hormone increases abdominal adiposity in hyperandrogenic anovulatory women
1998
Insulin secretory defects in polycystic ovary syndrome. Relationship to insulin sensitivity and family history of non-insulin-dependent diabetes mellitus.
1995
MetforminVersusEthinyl Estradiol-Cyproterone Acetate in the Treatment of Nonobese Women with Polycystic Ovary Syndrome: A Randomized Study
2003
Current Developments in the Molecular Genetics of the Polycystic Ovary Syndrome
1998
Differences in dyslipidemia between American and Italian women with polycystic ovary syndrome
2008
Is having polycystic ovary syndrome a predictor of poor psychological function including anxiety and depression?
2011
Obesity-Related Lipid Profile and Altered Insulin Incretion in Adolescents With Polycystic Ovary Syndrome
2010
Characterizing Discrete Subsets of Polycystic Ovary Syndrome as Defined by the Rotterdam Criteria: The Impact of Weight on Phenotype and Metabolic Features
2006
Prevalence of the Polycystic Ovary Syndrome in Unselected Black and White Women of the Southeastern United States: A Prospective Study1
1998 Standout
Hyperinsulinemia and circulating dehydroepiandrosterone sulfate in white and Mexican American women with polycystic ovary syndrome
2006
Effect of ovarian suppression on glucose metabolism of young lean women with and without ovarian hyperandrogenism
1999
Effects of metformin and ethinyl estradiol–cyproterone acetate on lipid levels in obese and non-obese women with polycystic ovary syndrome
2005
Impaired glucose tolerance, type 2 diabetes and metabolic syndrome in polycystic ovary syndrome: a systematic review and meta-analysis
2010
Smaller LDL particle size in women with polycystic ovary syndrome compared to controls
2001
DHEA, DHEAS and PCOS
2014
Treatment of obesity in polycystic ovary syndrome: a position statement of the Androgen Excess and Polycystic Ovary Syndrome Society
2008
Insulin Responses to the Oral Glucose Tolerance Test in Women of Different Ethnicity With Polycystic Ovary Syndrome
2005
Postnatal developmental consequences of altered insulin sensitivity in female sheep treated prenatally with testosterone
2005
A Modern Medical Quandary: Polycystic Ovary Syndrome, Insulin Resistance, and Oral Contraceptive Pills
2003
The Cardiovascular Risk of Young Women with Polycystic Ovary Syndrome: An Observational, Analytical, Prospective Case-Control Study
2004
Difference in dietary intake between women with polycystic ovary syndrome and healthy controls
2006
Defining ConstantVersusVariable Phenotypic Features of Women with Polycystic Ovary Syndrome Using Different Ethnic Groups and Populations
2006
Fasting Insulin Pulsatile Secretion in Lean Women with Polycystic Ovary Syndrome
2008
Diagnosis and management of the dermatologic manifestations of the polycystic ovary syndrome
2006
Diagnosis and Treatment of Polycystic Ovary Syndrome: An Endocrine Society Clinical Practice Guideline
2013 Standout
Obesity
2005 Standout
Maternal serum androgens in pregnant women with polycystic ovarian syndrome: possible implications in prenatal androgenization
2002
Insulin, androgens, and obesity in women with and without polycystic ovary syndrome: a heterogeneous group of disorders
1999
A C/T single nucleotide polymorphism at the tyrosine kinase domain of the insulin receptor gene is associated with polycystic ovary syndrome
2002
Follicular dynamics in the polycystic ovary syndrome
2000
Increased prevalence of anxiety symptoms in women with polycystic ovary syndrome: systematic review and meta-analysis
2011
Sex and gender: modifiers of health, disease, and medicine
2020 Standout
Androgen Excess Produces Systemic Oxidative Stress and Predisposes to β-Cell Failure in Female Mice
2010
Overweight and obese anovulatory patients with polycystic ovaries: parallel improvements in anthropometric indices, ovarian physiology and fertility rate induced by diet
2003
Combined oral contraceptives in the treatment of polycystic ovary syndrome
2005
Polycystic ovary syndrome and its developmental origins
2007
The Potential Implications of a PCOS Diagnosis on a Woman's Long-Term Health Using Data Linkage
2014
Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms
2004 Standout
Obesity and Cardiovascular Disease: A Scientific Statement From the American Heart Association
2021 Standout
Polycystic Ovary Syndrome
1995 Standout
Effect of pioglitazone on glucose metabolism and luteinizing hormone secretion in women with polycystic ovary syndrome
2006
The Metabolic Syndrome and Cardiovascular Risk
2010 Standout
Type 2 diabetes and cardiovascular disease in polycystic ovary syndrome: what are the risks and can they be reduced?
2010
Androgen and lipid profiles in adolescents with polycystic ovary syndrome who were treated with two forms of combined oral contraceptives
2002
Body size from birth to adulthood as a predictor of self-reported polycystic ovary syndrome symptoms
2003
Increased Risk for Abnormal Depression Scores in Women With Polycystic Ovary Syndrome
2010
Effective treatment of polycystic ovarian syndrome with Roux-en-Y gastric bypass
2005
Long-term consequences of polycystic ovary syndrome: Results of a 31 year follow-up study
2000
Obesity, rather than menstrual cycle pattern or follicle cohort size, determines hyperinsulinaemia, dyslipidaemia and hypertension in ageing women with polycystic ovary syndrome
2001
Relationship between Polycystic Ovarian Syndrome and Subsequent Gestational Diabetes Mellitus: A Nationwide Population-Based Study
2015
Clinical features in women with polycystic ovaries: relationships to insulin sensitivity, insulin gene VNTR and birth weight
2001
Does obesity diminish the positive effect of oral contraceptive treatment on hyperandrogenism in women with polycystic ovarian syndrome?
2001
Mechanisms linking obesity to insulin resistance and type 2 diabetes
2006 StandoutNature
Impaired insulin-dependent glucose metabolism in granulosa-lutein cells from anovulatory women with polycystic ovaries
2004
The genetic basis of polycystic ovary syndrome
1997
Treatment of PCOS in adolescence
2006
Metformin therapy throughout pregnancy reduces the development of gestational diabetes in women with polycystic ovary syndrome
2002
Estrogen and androgen receptors: regulators of fuel homeostasis and emerging targets for diabetes and obesity
2010
Endocrine and Metabolic Effects of MetforminVersusEthinyl Estradiol-Cyproterone Acetate in Obese Women with Polycystic Ovary Syndrome: A Randomized Study1
2000
Nutrition, hormones, and breast cancer: Is insulin the missing link?
1996
Polycystic Ovary Syndrome
2005 Standout
Review article: The impact of obesity on reproduction in women with polycystic ovary syndrome
2006
Pregnancy complications in women with polycystic ovary syndrome
2015
THE EPIDEMIOLOGY OF POLYCYSTIC OVARY SYNDROME
1999
Disparate genetic influences on polycystic ovary syndrome (PCOS) and type 2 diabetes revealed by a lack of association between common variants within the TCF7L2 gene and PCOS
2007
Association of variants in the fat mass and obesity associated (FTO) gene with polycystic ovary syndrome
2008
Epidemiology of gestational diabetes mellitus and its association with Type 2 diabetes
2004
IDF Diabetes Atlas: Global estimates for the prevalence of diabetes for 2015 and 2040
2017 Standout
New Approach to Polycystic Ovary Syndrome and Other Forms of Anovulatory Infertility
2002
Developmental origin of polycystic ovary syndrome - a hypothesis
2002
Altered Vascular Function in Young Women with Polycystic Ovary Syndrome
2002
Lipids and lipoprotein subfractions in women with PCOS: relationship to metabolic and endocrine parameters
2001
Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies
2008 Standout
β-Cell Function: A Key Pathological Determinant in Polycystic Ovary Syndrome
2005
Exercise therapy in polycystic ovary syndrome: a systematic review
2010
The prevalence of polycystic ovaries in women with a history of gestational diabetes
2000
Fecundability and spontaneous abortions in women with self-reported oligo-amenorrhea and/or hirsutism: Northern Finland Birth Cohort 1966 Study
2008
Disturbed stress responses in women with polycystic ovary syndrome
2009
Association of Insulin Gene VNTR Polymorphism with Polycystic Ovary Syndrome
2002
The Metabolic Syndrome in Polycystic Ovary Syndrome
2007
Increased risk of non-insulin dependent diabetes mellitus, arterial hypertension and coronary artery disease in perimenopausal women with a history of the polycystic ovary syndrome
2000
Correction of Hyperandrogenemia by Laparoscopic Ovarian Cautery in Women with Polycystic Ovarian Syndrome Is Not Accompanied by Improved Insulin Sensitivity or Lipid-Lipoprotein Levels1
1999
What We Talk About When We Talk About Fat
2014 Standout
Gender differences in glucose homeostasis and diabetes
2017
Polycystic ovary syndrome: Metabolic consequences and long-term management
2014
The natural history of the metabolic syndrome in young women with the polycystic ovary syndrome and the effect of long‐term oestrogen–progestagen treatment
1999
Polycystic ovary syndrome
1997
Consensus on women’s health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group
2011 Standout
Acute insulin response to intravenous glucagon in polycystic ovary syndrome
1998
Premature Response to Luteinizing Hormone of Granulosa Cells from Anovulatory Women with Polycystic Ovary Syndrome: Relevance to Mechanism of Anovulation1
1998
Polycystic Ovary Syndrome in the Adolescent
2009
INSULIN ACTION IN THE NORMAL AND POLYCYSTIC OVARY
1999
The serine phosphorylation hypothesis of polycystic ovary syndrome: a unifying mechanism for hyperandrogenemia and insulin resistance
2008
Elevated serum levels of tumor necrosis factor alpha in normal-weight women with polycystic ovary syndrome
1999
Obesity and the polycystic ovary syndrome
2002
Relative risk of conversion from normoglycaemia to impaired glucose tolerance or non-insulin dependent diabetes mellitus in polycystic ovarian syndrome
2001
The phenotype of polycystic ovary syndrome ameliorates with aging
2011
Polycystic ovary syndrome
2016 Standout
Inappropriate Gonadotropin Secretion in Polycystic Ovary Syndrome: Influence of Adiposity1
1997
Large-Scale Analysis of the Relationship betweenCYP11APromoter Variation, Polycystic Ovarian Syndrome, and Serum Testosterone
2004
ESHRE consensus on the definition of 'poor response' to ovarian stimulation for in vitro fertilization: the Bologna criteria
2011 Standout
Prevalence and Predictors of Risk for Type 2 Diabetes Mellitus and Impaired Glucose Tolerance in Polycystic Ovary Syndrome: A Prospective, Controlled Study in 254 Affected Women1
1999 Standout
Beta-cell dysfunction independent of obesity and glucose intolerance in the polycystic ovary syndrome.
1996
Linkage and association of insulin gene VNTR regulatory polymorphism with polycystic ovary syndrome
1997
Trend of Cardio-Metabolic Risk Factors in Polycystic Ovary Syndrome: A Population-Based Prospective Cohort Study
2015
Prevalence of the metabolic syndrome in Asian women with polycystic ovary syndrome: Using the International Diabetes Federation criteria
2007
Phenotypic characteristics according to insulin sensitivity in non-obese Korean women with polycystic ovary syndrome
2007
Relationship between E23K (an established type II diabetes-susceptibility variant within KCNJ11), polycystic ovary syndrome and androgen levels
2007
Early Endocrine, Metabolic, and Sonographic Characteristics of Polycystic Ovary Syndrome (PCOS): Comparison between Nonobese and Obese Adolescents
2003
Overweight, obesity and central obesity in women with polycystic ovary syndrome: a systematic review and meta-analysis
2012
Emergence of ovulatory cycles with aging in women with polycystic ovary syndrome (PCOS) alters the trajectory of cardiovascular and metabolic risk factors
2013
Failure of the homeostatic model assessment calculation score for detecting metabolic deterioration in young patients with polycystic ovary syndrome
2006
Risk of adverse pregnancy outcomes in women with polycystic ovary syndrome: population based cohort study
2011
Effect of hypocaloric diet plus sibutramine treatment on hormonal and metabolic features in overweight and obese women with polycystic ovary syndrome: a randomized, 24-week study
2007
Incretin levels in polycystic ovary syndrome
2008
Pre-eclampsia
2015 Standout
Anxiety and depression symptoms in women with polycystic ovary syndrome compared with controls matched for body mass index
2009
Birth weight in offspring of mothers with polycystic ovarian syndrome
2005
Birth Weight and Polycystic Ovary Syndrome in Adult Life: Is There a Causal Link?
2015
Pregnancy outcome in women with PCOS and in controls matched by age and weight
2003
Long-term health consequences of PCOS
2002
A randomized trial of the effects of two types of short-term hypocaloric diets on weight loss in women with polycystic ovary syndrome
2004
Prevalence of Infertility and Use of Fertility Treatment in Women with Polycystic Ovary Syndrome: Data from a Large Community-Based Cohort Study
2015
AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease
2023 Standout
Evidence-Based and Potential Benefits of Metformin in the Polycystic Ovary Syndrome: A Comprehensive Review
2008
The Complex Role of Estrogens in Inflammation
2007 Standout
Current Concepts in the Polycystic Ovary Syndrome
2001
Pathophysiology of Human Visceral Obesity: An Update
2013 Standout
Criteria for Defining Polycystic Ovary Syndrome as a Predominantly Hyperandrogenic Syndrome: An Androgen Excess Society Guideline
2006 Standout
Comparison of Simvastatin and Metformin in Treatment of Polycystic Ovary Syndrome: Prospective Randomized Trial
2009
Metabolic and Reproductive Features before and during Puberty in Daughters of Women with Polycystic Ovary Syndrome
2009
EDC-2: The Endocrine Society's Second Scientific Statement on Endocrine-Disrupting Chemicals
2015 Standout
Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility
2012
POSITION STATEMENT: Glucose Intolerance in Polycystic Ovary Syndrome—A Position Statement of the Androgen Excess Society
2007
Mechanisms of Insulin Action and Insulin Resistance
2018 Standout
Tirzepatide Once Weekly for the Treatment of Obesity
2022 Standout
Vascular Endothelial Growth Factor: Basic Science and Clinical Progress
2004 Standout
Assessment of Cardiovascular Risk and Prevention of Cardiovascular Disease in Women with the Polycystic Ovary Syndrome: A Consensus Statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society
2010
Health Consequences of Obesity in Youth: Childhood Predictors of Adult Disease
1998 Standout
Endocrine-Disrupting Chemicals: An Endocrine Society Scientific Statement
2009 Standout
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
2019 Standout
Polycystic Ovarian Syndrome: Long-Term Health Consequences
2017
The Insulin-Related Ovarian Regulatory System in Health and Disease
1999
Sex steroids and insulin resistance
2002
Obesity, endogenous hormones, and endometrial cancer risk: a synthetic review.
2002
Polycystic Ovary Syndrome and Ovulation Induction
2007
The Molecular-Genetic Basis of Functional Hyperandrogenism and the Polycystic Ovary Syndrome
2005
The role of androgens in metabolism, obesity, and diabetes in males and females
2015
A New Rat Model Exhibiting Both Ovarian and Metabolic Characteristics of Polycystic Ovary Syndrome
2007
Consensus on women's health aspects of polycystic ovary syndrome (PCOS)
2011
Sex and Gender Differences in Risk, Pathophysiology and Complications of Type 2 Diabetes Mellitus
2016 Standout
The insulin resistance in women with hyperandrogenism is partially reversed by antiandrogen treatment: evidence that androgens impair insulin action in women.
1996
Estrogen Receptor Null Mice: What Have We Learned and Where Will They Lead Us?
1999 Standout
Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
2018 Standout
Determinants of Abnormal Gonadotropin Secretion in Clinically Defined Women with Polycystic Ovary Syndrome1
1997
Hormonal Profile of Women with Self-Reported Symptoms of Oligomenorrhea and/or Hirsutism: Northern Finland Birth Cohort 1966 Study
2003
Hyperinsulinemia in postpubertal girls with a history of premature pubarche and functional ovarian hyperandrogenism.
1996
Polycystic Ovary Syndrome and Cardiovascular Disease: A Premature Association?
2003
Anti-Mullerian Hormone Levels in Peripubertal Daughters of Women with Polycystic Ovary Syndrome
2007
Insulin resistance and upper-body obesity in polycystic ovary syndrome
2007
Insulin Resistance and the Polycystic Ovary Syndrome: Mechanism and Implications for Pathogenesis*
1997 Standout
Scientific Statement on the Diagnostic Criteria, Epidemiology, Pathophysiology, and Molecular Genetics of Polycystic Ovary Syndrome
2015
Metabolic features of polycystic ovary syndrome are found in adolescent girls with hyperandrogenism.
1995
American Association of Clinical Endocrinologists and American College of Endocrinology Comprehensive Clinical Practice Guidelines For Medical Care of Patients with Obesity
2016
Adrenal Function during Childhood and Puberty in Daughters of Women with Polycystic Ovary Syndrome
2009
Alterations in cardiac flow parameters in patients with polycystic ovarian syndrome
1999
Once-Weekly Semaglutide in Adults with Overweight or Obesity
2021 Standout
The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders
2011 Standout
Beneficial Effects of a Three-Month Structured Exercise Training Program on Cardiopulmonary Functional Capacity in Young Women with Polycystic Ovary Syndrome
2007
Early origins of polycystic ovary syndrome
2005
Global Adiposity Rather Than Abnormal Regional Fat Distribution Characterizes Women with Polycystic Ovary Syndrome
2007
Ovarian Function and Metabolic Factors in Women with Oligomenorrhea Treated with Metformin in a Randomized Double Blind Placebo-Controlled Trial
2002
Cardiometabolic Aspects of the Polycystic Ovary Syndrome
2012
A Prospective Study of the Prevalence of the Polycystic Ovary Syndrome in Unselected Caucasian Women from Spain1
2000 Standout
Restoration of Reproductive Potential by Lifestyle Modification in Obese Polycystic Ovary Syndrome: Role of Insulin Sensitivity and Luteinizing Hormone1
1999
Dietary Composition in Restoring Reproductive and Metabolic Physiology in Overweight Women with Polycystic Ovary Syndrome
2003
Insulin-Lowering Agents in the Management of Polycystic Ovary Syndrome
2003
American Association of Clinical Endocrinologists Position Statement on Metabolic and Cardiovascular Consequences of Polycystic Ovary Syndrome
2005
Polycystic ovary syndrome is associated with negatively variable impacts on domains of health-related quality of life: evidence from a meta-analysis
2011
Glucose Intolerance in a Large Cohort of Mediterranean Women With Polycystic Ovary Syndrome
2004
Early Metabolic Derangements in Daughters of Women with Polycystic Ovary Syndrome
2007
The Timing of Normal Puberty and the Age Limits of Sexual Precocity: Variations around the World, Secular Trends, and Changes after Migration
2003 Standout
The Metabolic Syndrome
2008 Standout
Insulin Sensitivity in Women with Polycystic Ovary Syndrome
2004
Metabolic Profile in Sons of Women with Polycystic Ovary Syndrome
2008
Insulin Resistance and the Polycystic Ovary Syndrome Revisited: An Update on Mechanisms and Implications
2012 Standout
Genetic Basis of Metabolic Abnormalities in Polycystic Ovary Syndrome
2004
Assessment and management of polycystic ovary syndrome: summary of an evidence‐based guideline
2011
A Unique Defect in the Regulation of Visceral Fat Cell Lipolysis in the Polycystic Ovary Syndrome as an Early Link to Insulin Resistance
2002
Metabolic effects of oral contraceptives in women with polycystic ovary syndrome.
1995
Role of Brain Insulin Receptor in Control of Body Weight and Reproduction
2000 StandoutScience
Polycystic Ovary Syndrome, Depression, and Affective Disorders
2009
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
2019 Standout
Insulin, somatotropic, and luteinizing hormone axes in lean and obese women with polycystic ovary syndrome: common and distinct features.
1996
Works of Jan Holte being referenced
Menstrual cycle length is an age-independent marker of female fertility: results from 6271 treatment cycles of in vitro fertilization
2007
Is there a role for leptin in the endocrine and metabolic aberrations of polycystic ovary syndrome?
1998
Elevated ambulatory day-time blood pressure in women with polycystic ovary syndrome: a sign of a pre-hypertensive state?
1996
Polycystic ovary syndrome and insulin resistance: Thrifty genes struggling with over-feeding and sedentary life style?
1998
High Prevalence of Polycystic Ovaries and Associated Clinical, Endocrine, and Metabolic Features in Women with Previous Gestational Diabetes Mellitus
1998
Serum lipoprotein lipid profile in women with the polycystic ovary syndrome: relation to anthropometric, endocrine and metabolic variables
1994
Prevalence of the metabolic syndrome in women with a previous diagnosis of polycystic ovary syndrome: long-term follow-up
2011
Long-term follow-up of patients with polycystic ovary syndrome: reproductive outcome and ovarian reserve
2009
The counterregulatory response to hypoglycaemia in women with the polycystic ovary syndrome
1997
Disturbances in insulin secretion and sensitivity in women with the polycystic ovary syndrome
1996
Androgen levels, insulin sensitivity, and early insulin response in women with polycystic ovary syndrome: a long-term follow-up study
2010
Sexuality and psychological wellbeing in women with polycystic ovary syndrome compared with healthy controls
2011
Diabetes and impaired glucose tolerance in patients with polycystic ovary syndrome--a long term follow-up
2011
Construction of an evidence-based integrated morphology cleavage embryo score for implantation potential of embryos scored and transferred on day 2 after oocyte retrieval
2006
The independent effects of polycystic ovary syndrome and obesity on serum concentrations of gonadotrophins and sex steroids in premenopausal women
1994
Women with polycystic ovary syndrome are often depressed or anxious—A case control study
2008
Effects of androgens on aromatase activity and 11C‐vorozole binding in granulosa cells in vitro
2003
Enhanced early insulin response to glucose in relation to insulin resistance in women with polycystic ovary syndrome and normal glucose tolerance
1994
Response of the Pituitary-Adrenal Axis to Hypoglycemic Stress in Women with the Polycystic Ovary Syndrome
1999
Restored insulin sensitivity but persistently increased early insulin secretion after weight loss in obese women with polycystic ovary syndrome
1995
Enhanced early insulin response to glucose in relation to insulin resistance in women with polycystic ovary syndrome and normal glucose tolerance.
1994
Preserved Insulin Sensitivity and β-Cell Activity, but Decreased Glucose Effectiveness in Normal-Weight Women with the Polycystic Ovary Syndrome
2005
High Prevalence of Polycystic Ovaries and Associated Clinical, Endocrine, and Metabolic Features in Women with Previous Gestational Diabetes Mellitus
1998
Effects of androgens on aromatase activity and 11 C-vorozole binding in granulosa cells in vitro
2003
Restored insulin sensitivity but persistently increased early insulin secretion after weight loss in obese women with polycystic ovary syndrome.
1995